Association of diabetes and HbA 1c levels with gastrointestinal manifestations

Diabetes Care

Volumn 35, Issue 5, 2012, Pages 1053-1060

  Tseng, Ping Huei ^a,b   Lee, Yi Chia ^a,c   Chiu, Han Mo ^a   Chen, Chien Chuan ^a   Liao, Wei Chih ^a   Tu, Chia Hung ^a,c   Yang, Wei Shiung ^a,b,c   Wu, Ming Shiang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BARRETT ESOPHAGUS; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COLON TUMOR; COLONOSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ESOPHAGOGASTRODUODENOSCOPY; ETHNIC GROUP; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT EXAMINATION; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MEDICAL HISTORY; NON INVASIVE PROCEDURE; OCCULT BLOOD; PEPTIC ULCER; POPULATION RESEARCH; PREVALENCE; REFLUX ESOPHAGITIS; RISK ASSESSMENT; SMOKING; STOMACH TUMOR; AGED; GASTROINTESTINAL DISEASE; METABOLISM; MIDDLE AGED;

ADULT; AGED; DIABETES MELLITUS; FEMALE; GASTROINTESTINAL DISEASES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 84862084648     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1596     Document Type: Article

References (40)

1. Tseng CH, Tseng CP, Chong CK, et al. Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 2006;49: 1755-1760 (Pubitemid 44025029)
2. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001;161:1989-1996
3. Ko GT, Chan WB, Chan JC, Tsang LW, Cockram CS. Gastrointestinal symptoms in Chinese patients with type 2 diabetes mellitus. Diabet Med 1999;16:670-674
4. Talley NJ, Young L, Bytzer P, et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol 2001;96:71-76 (Pubitemid 32104810)
5. Frøkjaer JB, Søfteland E, Graversen C, et al. Central processing of gut pain in diabetic patients with gastrointestinal symptoms. Diabetes Care 2009;32:1274-1277
6. Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001;24:371-381 (Pubitemid 32119141)
7. Lam EK, Batty GD, Huxley RR, et al.; Asia Pacific Cohort Studies Collaboration. Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. Ann Oncol 2011;22:730-738
8. Maleki D, Locke GR 3rd, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 2000; 160:2808-2816
9. Anastasios R, Goritsas C, Papamihail C, Trigidou R, Garzonis P, Ferti A. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med 2002;13:376
10. Boehme MW, Autschbach F, Ell C, Raeth U. Prevalence of silent gastric ulcer, erosions or severe acute gastritis in patients with type 2 diabetes mellitus - a cross-sectional study. Hepatogastroenterology 2007;54:643-648 (Pubitemid 46724748)
11. Quatrini M, Boarino V, Ghidoni A, Baldassarri AR, Bianchi PA, Bardella MT. Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol 2001;32:215-217 (Pubitemid 32174111)
12. Holub JL, Silberg DG, Michaels LC, Williams JL, Morris CD, Eisen G. Acid-related upper endoscopy findings in patients with diabetes versus non-diabetic patients. Dig Dis Sci 2010;55:2853-2859
13. Chiu HM, Lin JT, Shun CT, et al. Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin Gastroenterol Hepatol 2007;5:221-229; quiz 141
14. Lee YC, Yen AM, Tai JJ, et al. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 2009;58:174-181
15. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479
16. American Diabetes Association. Standards of medical care in diabetesd2010. Diabetes Care 2010;33(Suppl. 1):S11-S61
17. Huang TM, Wu VC, Young GH, et al.; National Taiwan University Hospital Study Group of Acute Renal Failure. Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting. J Am Soc Nephrol 2011;22:156-163
18. Aptel F, Denis P, Rouberol F, Thivolet C. Screening of diabetic retinopathy: effect of field number and mydriasis on sensitivity and specificity of digital fundus photography. Diabetes Metab 2008;34:290-293
19. Chiang TH, Lee YC, Tu CH, Chiu HM, Wu MS. Performance of the immuno-chemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract. CMAJ 2011;183:1474-1481
20. Chen LS, Liao CS, Chang SH, Lai HC, Chen TH. Cost-effectiveness analysis for determining optimal cut-off of immuno-chemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16). J Med Screen 2007;14:191-199 (Pubitemid 350223783)
21. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180 (Pubitemid 29333764)
22. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001;120:636-651 (Pubitemid 32171637)
23. World Health Organization. Tumours of the colon and rectum. In World Health Organization Classifications of Tumors: Pathology and Genetics of Tumors of the Digestive System. Hamilton SR, Aaltonen LA, Eds. Lyon, France, IARC, 2000, p. 103-142
24. Parkman HP, Schwartz SS. Esophagitis and gastroduodenal disorders associated with diabetic gastroparesis. Arch Intern Med 1987;147:1477-1480 (Pubitemid 17122124)
25. Horikawa A, Ishii-Nozawa R, Ohguro M, et al. Prevalence of GORD (gastrooesophageal reflux disease) in type 2 diabetes and a comparison of clinical profiles between diabetic patients with and without GORD. Diabet Med 2009;26:228-233
26. Weil J, Langman MJ, Wainwright P, et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000;46:27-31 (Pubitemid 30307672)
27. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol 2002;97:604-611 (Pubitemid 34245887)
28. Lu CL, Chang SS, Wang SS, Chang FY, Lee SD. Silent peptic ulcer disease: frequency, factors leading to "silence," and implications regarding the pathogenesis of visceral symptoms. Gastrointest Endosc 2004;60:34-38
29. Mellem H, Stave R, Myren J, et al. Symptoms in patients with peptic ulcer and hematemesis and/or melena related to the use of non-steroid anti-inflammatory drugs. Scand J Gastroenterol 1985;20:1246-1248 (Pubitemid 16192626)
30. Jin HY, Kang YM, Kim CY, et al. Morphological comparison of small nerve fibres in gastricmucosa in non-diabetic and type 2 diabetic subjects. Diabet Med 2009;26:943-946
31. Selim MM, Wendelschafer-Crabb G, Redmon JB, et al. Gastric mucosal nerve density: a biomarker for diabetic autonomic neuropathy? Neurology 2010;75:973-981
32. Schimke K, Chubb SA, Davis WA, Phillips P, Davis TM. Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the Fremantle Diabetes Study. Diabet Med 2009;26:70-75
33. Thomsen RW, Riis A, Christensen S, Nørgaard M, Sørensen HT. Diabetes and 30-day mortality from peptic ulcer bleeding and perforation: a Danish population-based cohort study. Diabetes Care 2006;29:805-810 (Pubitemid 44115298)
34. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97:1679-1687 (Pubitemid 41672234)
35. Keku TO, Lund PK, Galanko J, Simmons JG, Woosley JT, Sandler RS. Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2005;14:2076-2081 (Pubitemid 41603248)
36. Kim BJ, Kim YH, Sinn DH, et al. Clinical usefulness of glycosylated hemoglobin as a predictor of adenomatous polyps in the colorectum of middle-aged males. Cancer Causes Control 2010;21:939-944
37. Chang C, Lu F, Yang YC, et al. Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Res Clin Pract 2000;50(Suppl. 2): S49-S59
38. Chen TH, Chiu YH, Luh DL, et al.; Taiwan Community-Based Integrated Screening Group. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 2004;100:1734-1743 (Pubitemid 38456353)
39. Levin B, Lieberman DA, McFarland B, et al.; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-1595 (Pubitemid 351615355)
40. Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005;3:55-59 (Pubitemid 40092944)